Literature DB >> 12659948

Functional and molecular characteristics of system L in human breast cancer cells.

D B Shennan1, J Thomson, M C Barber, M T Travers.   

Abstract

The functional and molecular properties of system L in human mammary cancer cells (MDA-MB-231 and MCF-7) have been examined. All transport experiments were conducted under Na(+)-free conditions. alpha-Aminoisobutyric acid (AIB) uptake by MDA-MB-231 and MCF-7 cells was almost abolished by BCH (2-amino-2-norbornane-carboxylic acid). AIB uptake by MDA-MB-231 cells was also inhibited by L-alanine (83.6%), L-lysine (75.6%) but not by L-proline. Similarly, L-lysine and L-alanine, respectively, reduced AIB influx into MCF-7 cells by 45.3% and 63.7%. The K(m) of AIB uptake into MDA-MB-231 and MCF-7 cells was, respectively, 1.6 and 8.8 mM, whereas the V(max) was, respectively, 9.7 and 110.0 nmol/mg protein/10 min. AIB efflux from MDA-MB-231 and MCF-7 cells was trans-stimulated by BCH, L-glutamine, L-alanine, L-leucine, L-lysine and AIB (all at 2 mM). In contrast, L-glutamate, L-proline, L-arginine and MeAIB had no effect. The interaction between L-lysine and AIB efflux was one of low affinity. The fractional release of AIB from MDA-MB-231 cells was trans-accelerated by D-leucine and D-tryptophan but not by D-alanine. MDA-MB-231 and MCF-7 cells expressed LAT1 and CD98 mRNA. MCF-7 cells also expressed LAT2 mRNA. The results suggest that AIB transport in mammary cancer cells under Na(+)-free conditions is predominantly via system L which acts as an exchange mechanism. The differences in the kinetics of AIB transport between MDA-MB-231 and MCF-7 cells may be due to the differential expression of LAT2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12659948     DOI: 10.1016/s0005-2736(03)00028-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies.

Authors:  Csaba Juhász; Zeina Nahleh; Ian Zitron; Diane C Chugani; Majid Z Janabi; Sudeshna Bandyopadhyay; Rouba Ali-Fehmi; Thomas J Mangner; Pulak K Chakraborty; Sandeep Mittal; Otto Muzik
Journal:  Nucl Med Biol       Date:  2012-03-22       Impact factor: 2.408

2.  LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

Authors:  Kuniaki Nakanishi; Hirotaka Matsuo; Yoshikatsu Kanai; Hitoshi Endou; Sadayuki Hiroi; Susumu Tominaga; Makio Mukai; Eiji Ikeda; Yuichi Ozeki; Shinsuke Aida; Toshiaki Kawai
Journal:  Virchows Arch       Date:  2005-09-21       Impact factor: 4.064

Review 3.  L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.

Authors:  Qian Wang; Jeff Holst
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

4.  Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells.

Authors:  Barbara Stöber; Ursula Tanase; Michael Herz; Christof Seidl; Markus Schwaiger; Reingard Senekowitsch-Schmidtke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-08       Impact factor: 9.236

Review 5.  CD98 at the crossroads of adaptive immunity and cancer.

Authors:  Joseph M Cantor; Mark H Ginsberg
Journal:  J Cell Sci       Date:  2012-04-12       Impact factor: 5.285

6.  123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients.

Authors:  Marleen Keyaerts; Tony Lahoutte; Bart Neyns; Vicky Caveliers; Chris Vanhove; Hendrik Everaert; Ken Kersemans; Philippe R Franken; John Mertens; Axel Bossuyt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-20       Impact factor: 9.236

7.  Severe tryptophan starvation blocks onset of conventional persistence and reduces reactivation of Chlamydia trachomatis.

Authors:  Ralf M Leonhardt; Seung-Joon Lee; Paula B Kavathas; Peter Cresswell
Journal:  Infect Immun       Date:  2007-08-27       Impact factor: 3.441

8.  Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.

Authors:  Justin K Tomblin; Subha Arthur; Donald A Primerano; Ateeq R Chaudhry; Jun Fan; James Denvir; Travis B Salisbury
Journal:  Biochem Pharmacol       Date:  2016-03-02       Impact factor: 5.858

9.  Potential Biomarker of L-type Amino Acid Transporter 1 in Breast Cancer Progression.

Authors:  Zhongxing Liang; Heidi T Cho; Larry Williams; Aizhi Zhu; Ke Liang; Ke Huang; Hui Wu; Chunsu Jiang; Samuel Hong; Ronald Crowe; Mark M Goodman; Hyunsuk Shim
Journal:  Nucl Med Mol Imaging       Date:  2010-11-24

10.  Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract.

Authors:  Kuniaki Nakanishi; Sho Ogata; Hirotaka Matsuo; Yoshikatsu Kanai; Hitoshi Endou; Sadayuki Hiroi; Susumu Tominaga; Shinsuke Aida; Hiroyasu Kasamatsu; Toshiaki Kawai
Journal:  Virchows Arch       Date:  2007-07-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.